Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Projected top 10 pharmaceutical companies worldwide by revenue in 2019 (in billion U.S. dollars)*
Projection of top 10 global pharmaceutical companies by revenue 2019
Like in the years before, Pfizer is again expected to be the world’s largest pharmaceutical company in 2019, based on pharmaceutical-only sales. Pfizer will probably generate around 48 billion U.S. dollars through sales of prescribed and over-the-counter drugs. In many top pharmaceutical companies’ rankings Johnson & Johnson is listed as the biggest pharmaceutical company. Albeit, these rankings take into account J&J’s total revenue which consists to a large extent of non-pharmaceutical sales from its medical device and consumer health segments.

A global view on the industry

The total global pharmaceutical market reached some 1.2 trillion U.S. dollars in 2018. North America remains the strongest regional market worldwide, responsible for nearly half of the global market size. The largest national pharmaceutical market is the United States with some 450 billion U.S. dollars in medicine spending. Thus, six of the ten largest pharmaceutical companies worldwide were from the United States in 2017. One reason for this is that the U.S. is still the world’s largest hub for life sciences and medical research and knowledge.

The importance of innovation

Pharmaceutical companies are to a very large part – more than in most other industries – driven by the imperative to produce innovative products and to invest in research and development. Once a new drug, for example, is launched, the clock is already ticking towards the loss of patent protection. In particular, companies that depend on a small number of blockbuster drugs, are under threat of heavy revenue loss. Two effects of patent expirations for the pharma industry are high R&D concentration and a growing focus on specialty drugs.
Projected top 10 pharmaceutical companies worldwide by revenue in 2019 (in billion U.S. dollars)*
Product revenue in billion U.S. dollars
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

December 2018

Region

Worldwide

Survey time period

as of November 2018

Supplementary notes

* Including Rx and OTC sales.

Projection of top 10 global pharmaceutical companies by revenue 2019
Like in the years before, Pfizer is again expected to be the world’s largest pharmaceutical company in 2019, based on pharmaceutical-only sales. Pfizer will probably generate around 48 billion U.S. dollars through sales of prescribed and over-the-counter drugs. In many top pharmaceutical companies’ rankings Johnson & Johnson is listed as the biggest pharmaceutical company. Albeit, these rankings take into account J&J’s total revenue which consists to a large extent of non-pharmaceutical sales from its medical device and consumer health segments.

A global view on the industry

The total global pharmaceutical market reached some 1.2 trillion U.S. dollars in 2018. North America remains the strongest regional market worldwide, responsible for nearly half of the global market size. The largest national pharmaceutical market is the United States with some 450 billion U.S. dollars in medicine spending. Thus, six of the ten largest pharmaceutical companies worldwide were from the United States in 2017. One reason for this is that the U.S. is still the world’s largest hub for life sciences and medical research and knowledge.

The importance of innovation

Pharmaceutical companies are to a very large part – more than in most other industries – driven by the imperative to produce innovative products and to invest in research and development. Once a new drug, for example, is launched, the clock is already ticking towards the loss of patent protection. In particular, companies that depend on a small number of blockbuster drugs, are under threat of heavy revenue loss. Two effects of patent expirations for the pharma industry are high R&D concentration and a growing focus on specialty drugs.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.